Oberweis Asset Management Inc Atri Cure, Inc. Transaction History

Oberweis Asset Management Inc

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$32.99 - $43.25 $719,182 - $942,850	21,800 Added 46.09%	69,100 $2.47 Million
Q3 2023 Nov 14, 2023	BUY	$41.12 - $57.73 $1.94 Million - $2.73 Million	47,300 New	47,300 $2.07 Million
Q4 2019 Feb 14, 2020	SELL	$24.06 - $32.51 $3.36 Million - $4.54 Million	-139,600 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$23.81 - $32.52 $1.56 Million - $2.13 Million	-65,350 Reduced 31.89%	139,600 $3.48 Million
Q2 2019 Aug 14, 2019	BUY	$26.85 - $30.74 $41,349 - $47,339	1,540 Added 0.76%	204,950 $6.12 Million
Q1 2019 May 15, 2019	SELL	$26.38 - $33.34 $730,989 - $923,851	-27,710 Reduced 11.99%	203,410 $5.45 Million
Q4 2018 Feb 14, 2019	SELL	$26.66 - $34.85 $189,019 - $247,086	-7,090 Reduced 2.98%	231,120 $7.07 Million
Q3 2018 Nov 14, 2018	BUY	$27.62 - $35.58 $311,857 - $401,733	11,291 Added 4.98%	238,210 $8.34 Million
Q2 2018 Aug 14, 2018	BUY	$19.65 - $30.28 $4.46 Million - $6.87 Million	226,919 New	226,919 $6.14 Million

212

49.7M

12K

7.2K

Ticker ATRC
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 46,424,700
Market Cap $1.43B
Description
AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems, and intercostal nerves to medical centers in the United States, Europe, Asia, and internationally. The company offers Isolator Synergy Clamps, a single-use disposable radio frequency products; multifunctional pens and linear ablation...

Get notified when there are updates to the investment portfolio of Oberweis Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Oberweis Asset Management Inc with notifications on news.